Related Experiment Video
Updated: May 22, 2026
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing.
Timothy A Whitehead1, Aaron Chevalier, Yifan Song
1Department of Biochemistry, University of Washington, Seattle, Washington, USA.
Nature Biotechnology
|May 29, 2012
Summary
Deep sequencing of protein interactions enables enhanced antibody design. This method optimizes inhibitors against influenza hemagglutinin, yielding potent variants with broad reactivity and therapeutic potential.
Area of Science:
- Protein engineering
- Immunology
- Computational biology
Background:
- Optimizing protein interactions is crucial for therapeutic development.
- Traditional affinity maturation methods face limitations in capturing small, cumulative effects.
Purpose of the Study:
- To demonstrate the utility of deep sequencing for generating comprehensive sequence-function maps.
- To reprogram protein interaction specificity and overcome bottlenecks in affinity maturation.
- To engineer potent and broadly reactive influenza inhibitors.
Main Methods:
- Utilizing deep sequencing to create detailed sequence-function maps.
- Applying these maps to optimize computationally designed protein inhibitors.
- Testing inhibitor variants against influenza hemagglutinin (HA) for binding affinity and neutralizing activity.
Main Results:
- Achieved subnanomolar binding affinity for optimized inhibitors against H1N1 HA.
- Developed a 51-residue protein variant with broad cross-reactivity against influenza group 1 HAs, including H2.
- Demonstrated neutralization potency against H1N1 viruses comparable to human monoclonal antibodies.
Conclusions:
- Comprehensive sequence-function maps from deep sequencing are powerful tools for protein engineering.
- Computational design combined with energy landscape mapping can yield proteins with significant therapeutic potential.
- This approach accelerates the development of broadly protective antiviral agents.
